Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Carbonate Ion | HCID 19660 | — |
| Reactant | HCID 68903302 | HCID 68903302 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 25015462 | HCID 25015462 | — |
Reaction Steps
A solution of 0.050 g (0.00016 mole) of (rac)-2-chloro-9-cyclohexyl-5,7-dimethyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VII-19), 0.040 g (0.00016 mole) of 4-amino-3-methoxy-N-(1-methyl-piperidin-4-yl)-benzamide, 0.050 g of p-toluenesulfonic acid monohydratein 4.0 mL of 2-propanol was heated at 200 degrees for 1 hour in a microwave reactor. The reaction mixture was purified by C18 reverse phase chromatography, eluting with acetonitrile—water containing 0.075% trifluoroacetic acid to give 0.066 g of (rac)-4-(9-cyclohexyl-5,7-dimethyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-N-(1-methyl-piperidin-4-yl)-benzamide trifluoroacetic acid salt as a white powder. To a suspension of 0.066 of (rac)-4-(9-cyclohexyl-5,7-dimethyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-N-(1-methyl-piperidin-4-yl)-benzamide trifluoroacetic acid salt in tetrahydrofuran was added 0.25 g of SilicaBond Carbonate (Silicycle). The mixture was stirred at room temperature for 4 hours, then filtered and concentrated under reduced pressure. The residue was purified by silica gel chromatography eluting with dichloromethane-methanol (100:0-75:25) to give 0.041 g of (rac)-4-(9-cyclohexyl-5,7-dimethyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-N-(1-methyl-piperidin-4-yl)-benzamide (I-19) as a white powder. HRMS (ES+) m/z Calcd for C29H41N7O3+H [(M+H)+]: 536.3344. Found: 536.3343.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07517873B2 |
|---|
| Source dataset | uspto-grants-2009_04 |
|---|
| ORD ID | ord-7a9fa5c5d5424a6ab0faa538d0e2f2bf |
|---|
| Source note | uspto-grants-2009_04 |
|---|